69 related articles for article (PubMed ID: 22652095)
21. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
22. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
23. Breast MRI in the evaluation of eligibility for accelerated partial breast irradiation.
Godinez J; Gombos EC; Chikarmane SA; Griffin GK; Birdwell RL
AJR Am J Roentgenol; 2008 Jul; 191(1):272-7. PubMed ID: 18562758
[TBL] [Abstract][Full Text] [Related]
24. Comparison between high-resolution helical CT and pathology in breast examination.
Uematsu T; Sano M; Homma K; Sato N
Acta Radiol; 2002 Jul; 43(4):385-90. PubMed ID: 12225480
[TBL] [Abstract][Full Text] [Related]
25. MRI accurately depicts underlying DCIS in a patient with Paget's disease of the breast without palpable mass and mammography findings.
Amano G; Yajima M; Moroboshi Y; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2005 Mar; 35(3):149-53. PubMed ID: 15741305
[TBL] [Abstract][Full Text] [Related]
26. Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study.
Warner E; Causer PA; Wong JW; Wright FC; Jong RA; Hill KA; Messner SJ; Yaffe MJ; Narod SA; Plewes DB
Breast J; 2011; 17(1):9-17. PubMed ID: 21251121
[TBL] [Abstract][Full Text] [Related]
27. Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapy.
Schmitz AC; van den Bosch MA; Loo CE; Mali WP; Bartelink H; Gertenbach M; Holland R; Peterse JL; Rutgers EJ; Gilhuijs KG
Radiother Oncol; 2010 Nov; 97(2):225-32. PubMed ID: 20826026
[TBL] [Abstract][Full Text] [Related]
28. Targeting difficult accessible breast lesions: MRI-guided needle localization using a freehand technique in a 3.0 T closed bore magnet.
Meeuwis C; Peters NH; Mali WP; Gallardo AM; van Hillegersberg R; Schipper ME; van den Bosch MA
Eur J Radiol; 2007 May; 62(2):283-8. PubMed ID: 17218074
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer tumor size: correlation between magnetic resonance imaging and pathology measurements.
Onesti JK; Mangus BE; Helmer SD; Osland JS
Am J Surg; 2008 Dec; 196(6):844-48; discussion 849-50. PubMed ID: 19095098
[TBL] [Abstract][Full Text] [Related]
30. Potential impact of preoperative magnetic resonance imaging of the breast on patient selection for accelerated partial breast irradiation.
Kühr M; Wolfgarten M; Stölzle M; Leutner C; Höller T; Schrading S; Kuhl C; Schild H; Kuhn W; Braun M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e541-6. PubMed ID: 21664064
[TBL] [Abstract][Full Text] [Related]
31. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
32. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
33. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
Rodrigues NA; Dillon D; Carter D; Parisot N; Haffty BG
Cancer; 2003 Mar; 97(6):1393-403. PubMed ID: 12627502
[TBL] [Abstract][Full Text] [Related]
34. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
35. Preoperative breast MRI in the surgical treatment of ductal carcinoma in situ.
Kropcho LC; Steen ST; Chung AP; Sim MS; Kirsch DL; Giuliano AE
Breast J; 2012; 18(2):151-6. PubMed ID: 22211816
[TBL] [Abstract][Full Text] [Related]
36. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
37. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ.
Solin LJ; Orel SG; Hwang WT; Harris EE; Schnall MD
J Clin Oncol; 2008 Jan; 26(3):386-91. PubMed ID: 18202414
[TBL] [Abstract][Full Text] [Related]
38. Recent advances and current controversies in the management of DCIS of the breast.
Sakorafas GH; Farley DR; Peros G
Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
[TBL] [Abstract][Full Text] [Related]
39. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
